- Home
- / MIRA Pharmaceuticals
MIRA Pharmaceuticals
Stock Price
$1.7
2024-10-29
Market Capitalization
$28.1 M
2024-10-29
MIRA Pharmaceuticals Summary
Company Summary
- Overview
- MIRA Pharmaceuticals is an early-stage life sciences company. It is focused on the development and commercialization of MIRA1a, treatment for anxiety and cognitive decline in the elderly and chronic pain.
- Type
- Public
- Status
- Active
- Founded
- 2022
- HQ
- Baltimore, MD, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Adam Kaplin, Cofounder, President, and Chief Scientific Officer
Michelle Yanez, Chief Financial Officer, Secretary, and Treasurer
Christos Nicholoudis, General Counsel
LocationsView all
1 location detected
Baltimore, MD HQ
United States
855 North Wolfe Street Suite 601
MIRA Pharmaceuticals Financials
Summary Financials
- Net income (Q1, 2026)
- ($1.2M)
- Cash (Q1, 2026)
- $4.8M